| Factor Information | |
|---|---|
| Data ID | 4032 |
| Factor | Modified Ross score |
| Description | Infra-tricuspid shunt group showed significantly higher levels of Modified Ross score than supra-tricuspid shunt group |
| Biomarker | NA |
| Classification | A6 (clinical factor - other) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To compare different clinical/hemodynamic parameters between infra-tricuspid shunt group and supra tricuspid shunt group. |
| p Value | 0.0004 |
| Conclusion | Infra-tricuspid shunt group showed significantly higher levels of Modified Ross score than supra-tricuspid shunt group |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 746 |
| CHD Type | isolated CHD |
| CHD Subtype | PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
| Reference | |
|---|---|
| PMID | 31883956 |
| Year | 2020 |
| Title | Growth differentiation factor 15 as a useful biomarker of heart failure in young patients with unrepaired congenital heart disease of left to right shunt. |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | patients | |
| Region | Kurume, Japan | |
| Method | N/A | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | underwent cardiac catheterization | |
| Group | infra-tricuspid shunt(Treatment) | supra-tricuspid shunt(Control) |
| Number | 26 | 42 |
| Age | 12.5 (1–114) months | 86 (5–173) months |
| Gender (Male: Female) | 9:17 | 20:22 |
| Marker Level | 1(1–10) | 0(0–5) |
